Navigation Links
ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
Date:3/5/2010

important study evaluating ISIS-SOD1Rx in people with familial ALS," said Merit Cudkowicz, M.D., Co-Chair of the Northeast ALS Consortium and a Professor of Neurology at the Massachusetts General Hospital of Harvard Medical School.

"It is evident that certain cases of familial ALS are related to mutant forms of SOD1.  Therefore, the selective inhibition of SOD1 production could provide a way to improve the outcomes of these patients with ALS," said Timothy Miller, M.D., Ph.D., Assistant Professor of Neurology at Washington University School of Medicine and Director of the Christopher Wells Hobler Laboratory for ALS Research at the Hope Center for Neurological Disorders.  "This is the first study to administer an inhibitor of SOD1 directly into the central nervous system.  Having been involved with Isis in the research and now the clinical development of ISIS-SOD1Rx, I am looking forward to co-chairing this study with Dr. Cudkowicz and the Northeast ALS Consortium."

"ISIS-SOD1Rx is our first antisense drug to enter clinical trials to treat a neurodegenerative disease and our first antisense drug to be administered directly into the central nervous system.  Based on our earlier preclinical studies, we believe that ISIS-SOD1Rx could offer an effective treatment for patients with familial ALS," said C. Frank Bennett, Ph.D., Senior Vice President of Research at Isis Pharmaceuticals.  "This study is the first step
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
2. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
3. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
4. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
5. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
6. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
7. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
8. Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
9. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
10. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
11. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015   Heska Corporation (NASDAQ: ... "Company"), a provider of advanced veterinary diagnostic and other ... , Executive Chair, will present at the 16th Annual B. ... May 13, 2015. The conference will be held May 12-14, ... Heska management will be available during the day ...
(Date:5/1/2015)... May 1, 2015 The Institute for Healthcare ... literacy award winners. The IHA Health Literacy Awards aim ... impact on the practice of educating or empowering organizations ... gives awards in three categories: innovative programs, published materials ... Literacy Hero award. In the area of ...
(Date:5/1/2015)... 1, 2015  Misonix, Inc. (NASDAQ: MSON ... manufactures and markets innovative therapeutic ultrasonic products for ... surgery, laparoscopic surgery and other surgical applications, announced ... the third quarter fiscal year 2015 on Thursday, ... conference call that same day, Thursday, May 7, ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Institute for Healthcare Advancement Announces 2015 Award Winners 2Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2
(Date:5/2/2015)... (PRWEB) May 02, 2015 ProText Kinetic 2 ... use in Final Cut Pro X. ProText Kinetic 2 ... in Final Cut Pro X . Easily create ... with Pixel Film Studios' ProText Kinetic 2. , Using ProText ... by staggering two ProText Kinetic presets in the FCPX timeline. ...
(Date:5/2/2015)... 2015 Kare Visits LLC. launched in Chicago ... caregivers. Kare Visits offers relief for caregivers by visiting ... According to the Caregiver Action Network, eight in ... 20 hours a week caring for an elderly or disabled ... hire a nurse, a caregiver is now empowered to schedule ...
(Date:5/1/2015)... BWI (PRWEB) May 02, 2015 The ... It is http://www.thevenetiangracebay.com , and it is elegant ... the stunning white and attractive turquoise hues of Grace ... Google, sixty seven percent of leisure travelers used their ... that smartphones were used in the planning and researching ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 TROY Healthcare ... Cerner Southeast Regional User Group (RUG) Conference in Atlanta, ... Southeast Regional User Group Conference provides a forum for ... who support all aspects of electronic medical record operations, ... Cerner software applications. , In addition to sponsoring the ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team raised over ... Quail Creek Relay team has raised almost $860,000. Quail ... including their biggest event, January’s Dinner and Auction; an annual ... Creek Relay for Life team was established to honor a ... states, “I was hooked when I learned how the money ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... being used more and more often to treat abdominal aortic ... ever older and sicker patients, the long-term survival of those ... two decades. This is shown in a major Swedish study ... findings are published in Circulation: Journal of the American ...
... 7 The Cystic Fibrosis Foundation announced today that all ... requiring that all newborns be screened for cystic fibrosis (CF) ... of cystic fibrosis, a life-threatening, genetic disease, can have a ... condition. , , Newborn screening for CF was adopted ...
... 7 Startech Environmental Corp. (OTC BB: STHK), a fully reporting, ... take any action with respect to the commencement of a tender ... purchase all of the outstanding shares of Startech for $0.65 per ... today said that it will carefully review the tender offer materials ...
... , NEWARK, N.J., July 7 BioNeutral Group, Inc. ... Science company announced today that independent laboratory testing performed ... are completely eliminated by the Company,s Ygiene(TM) Hospital Grade ... using the EPA required Fungicidal Use Dilution test, showed ...
... Fairfield County residents will have the opportunity to witness a ... the traditional lighting of the Saugatuck River Bridge at dusk. ... at the door, will enjoy cuisine and drink from some ... the chance to participate in a silent auction that includes ...
... July 7, 2009 AMERIGROUP Corporation (NYSE: AGP ... the second quarter ended June 30, 2009, at approximately 6:00 ... 8:30 a.m. Eastern Time on the same day, AMERIGROUP,s management ... and other information. , , To listen to the ...
Cached Medicine News:Health News:Operation for aneurysm yields nearly normal longevity 2Health News:All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 3Health News:Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores 2Health News:Independent Laboratory Testing Shows BioNeutral's Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores 3Health News:Al's Angels' 'Angels in July' Saugatuck River Bridge Lighting to Benefit Children in Need 2Health News:AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31 2
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... ADC drugs of abuse tests are highly accurate ... SAMHSA recommended cut-off as confirmed by GC/MS testing. ... more specific alternative method (such as GC/MS) must ... result. Professional judgment should be applied to any ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... quantitative microplate enzyme immunoassay that can identify bladder ... recurrence or occult disease. The test is performed ... twice as sensitive as urine cytology. Urologists can ... identifying those patients who may benefit from more ...
Medicine Products: